
Sign up to save your podcasts
Or


Send us a text
Editor-in-Chief, Robert Amdur, MD, discusses an article from the September/October issue of PRO, "Sparing the Larynx and Hypopharynx with Radiotherapy for Squamous Cell Carcinoma of Unknown Primary Site and Predominant Adenopathy in Level IIA" and gives his five principles for deciding which mucosal sites to treat with an unknown primary.
By Various4.5
3737 ratings
Send us a text
Editor-in-Chief, Robert Amdur, MD, discusses an article from the September/October issue of PRO, "Sparing the Larynx and Hypopharynx with Radiotherapy for Squamous Cell Carcinoma of Unknown Primary Site and Predominant Adenopathy in Level IIA" and gives his five principles for deciding which mucosal sites to treat with an unknown primary.
11,177 Listeners

320 Listeners

885 Listeners

291 Listeners

2,442 Listeners

3,331 Listeners

1,153 Listeners

44 Listeners

61 Listeners

208 Listeners

58 Listeners

189 Listeners

37 Listeners

3 Listeners

8 Listeners